Breadcrumb Home Yale Technologies Targeting Profibrotic Macrophages Using Mir-33 Inhibitors, a Novel Therapeutic Approach for Pulmonary Fibrosis Yale Life Sciences PitchFest 2022 12/08/2022 Targeting Profibrotic Macrophages Using Mir-33 Inhibitors, a Novel Therapeutic Approach for Pulmonary Fibrosis Download Pitch Presentation Ahangari, Farida - PitchFest2022.pptx (9.69 MB) Investigators Farida Ahangari Targeting Profibrotic Macrophages Using Mir-33 Inhibitors, a Novel Therapeutic Approach for Pulmonary Fibrosis
Farida Ahangari Targeting Profibrotic Macrophages Using Mir-33 Inhibitors, a Novel Therapeutic Approach for Pulmonary Fibrosis
